 |
PDBsum entry 4wzy
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.1.175
- maltokinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
D-maltose + ATP = alpha-maltose 1-phosphate + ADP + H+
|
 |
 |
 |
 |
 |
D-maltose
|
+
|
ATP
|
=
|
alpha-maltose 1-phosphate
Bound ligand (Het Group name = )
matches with 85.19% similarity
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Mg(2+)
|
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Sci Rep
5:8026
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of mycobacterial maltokinase, the missing link in the essential GlgE-pathway.
|
|
J.Fraga,
A.Maranha,
V.Mendes,
P.J.Pereira,
N.Empadinhas,
S.Macedo-Ribeiro.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
A novel four-step pathway identified recently in mycobacteria channels trehalose
to glycogen synthesis and is also likely involved in the biosynthesis of two
other crucial polymers: intracellular methylglucose lipopolysaccharides and
exposed capsular glucan. The structures of three of the intervening enzymes -
GlgB, GlgE, and TreS - were recently reported, providing the first templates for
rational drug design. Here we describe the structural characterization of the
fourth enzyme of the pathway, mycobacterial maltokinase (Mak), uncovering a
eukaryotic-like kinase (ELK) fold, similar to methylthioribose kinases and
aminoglycoside phosphotransferases. The 1.15 Å structure of Mak in complex
with a non-hydrolysable ATP analog reveals subtle structural rearrangements upon
nucleotide binding in the cleft between the N- and the C-terminal lobes.
Remarkably, this new family of ELKs has a novel N-terminal domain topologically
resembling the cystatin family of protease inhibitors. By interfacing with and
restraining the mobility of the phosphate-binding region of the N-terminal lobe,
Mak's unusual N-terminal domain might regulate its phosphotransfer activity and
represents the most likely anchoring point for TreS, the upstream enzyme in the
pathway. By completing the gallery of atomic-detail models of an essential
pathway, this structure opens new avenues for the rational design of alternative
anti-tubercular compounds.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |